Clinical Neuroscience Solutions, Inc

Summary

Clinical Neuroscience Solutions, Inc is a medical facility located in Orlando, Florida. This center is recognized for care of Depression, Attention-Deficit/Hyperactivity Disorder (ADHD), Major Depressive Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Migraine and other specialties. Clinical Neuroscience Solutions, Inc is involved with conducting 184 clinical trials across 105 conditions. There are 4 research doctors associated with this hospital, such as Robert Molpus, M.D, Tatyana Miroshnikova, Robert Bond Molpus, MD, and Michael Edward Dever.

Top PIs

Clinical Trials running at Clinical Neuroscience Solutions, Inc

Depression

COVID-19

Migraine

Bipolar Disorder

Coronavirus

I Am A Healthy Volunteer

Coronavirus Infection

Major Depressive Disorder

Atopic Dermatitis

Attention-Deficit/Hyperactivity Disorder (ADHD)

ACP-211

for Depression

The goal of this clinical trial is to learn if ACP-211 can help treat adults with major depressive disorder (MDD) who have not improved with antidepressant therapy (ADT), including those with treatment resistant depression (TRD). The main questions the study aims to answer are: * Does ACP-211 work better than a placebo (a look-alike capsule with no medicine) to reduce symptoms of depression? * What adverse events do participants have when taking ACP-211?

Recruiting

1 award

Phase 2

4 criteria

CYB003

for Depression

This study is for adults with major depressive disorder (MDD) who are still experiencing symptoms even while taking antidepressant medication.

Recruiting

1 award

Phase 3

7 criteria

SP-624

for Depression

This trial is testing the efficacy of an investigational drug, SP-624 (study drug) to see how well it might work to treat major depressive disorder.

Recruiting

0 awards

Phase 2

17 criteria